Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group
| Autor: | Wu, Tao *, Yang, Yong *, Zhu, Su-Yu, Shi, Mei, Su, Hang, Wang, Ying, He, Xia, Xu, Li-Ming, Yuan, Zhi-Yong, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Lan, Sheng-Min, Wu, Jun-Xin, Hu, Chen, Qi, Shu-Nan, Chen, Bo, Li, Ye-Xiong |
|---|---|
| Zdroj: | In Blood Advances 25 September 2018 2(18):2369-2377 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|